Table 2.
Intervention group (n = 29) | Control group (n = 23) | Between-group differences in | ||||
---|---|---|---|---|---|---|
mean change from baseline | ||||||
Variables | Baseline | 16-week | Baseline | 16-week | Δ (95% CI) | p |
follow-up | follow-up | |||||
VO2peak (ml/kg/min) | 21.9 (5.9) | 24.8 (7.4) | 25.9 (6.5) | 25.1 (5.5) | – 3.9 (– 6.3; – 1.5) | 0.003 |
VO2peak (ml/min) | 1,563 (448) | 1,771 (578) | 1,747 (564) | 1,635 (610) | – 330 (– 489; – 170) | 0.001 |
RER | 1.17 (0.14) | 1.13 (0.13) | 1.16 (0.13) | 1.14 (0.13) | – 0.03 (– 0.06; 0.00) | 0.087 |
HRmax (bpm) | 137 (24) | 136 (25) | 142 (21) | 142 (24) | – 3.4 (– 11.3; 4.6) | 0.402 |
Body weight (kg) | 72.3 (14.9) | 72.1 (15.9) | 67.3 (12.0) | 68.9 (12.5) | – 0.6 (– 2.1; 0.9) | 0.446 |
Baseline and 16-week follow-up with unadjusted mean±SD and mean outcomes of the Intervention Group compared to mean outcomes in Control Group, beyond the difference already present at baseline, adjusted for clustering within training groups and centers, RER: respiratory exchange ratio, HRmax: maximal heart rate.